medonline
News
Lernwelt
Themenwelt
Pharmazie
Webkiosk
Dr. Mohammed Milhem
Posts by Dr. Mohammed Milhem
CMP-001
Mohammed Milhem on the combination of CMP-001 + Pembro
Mohammed Milhem presents preliminary data on the combination of the TLR9 agonist CMP-001 and pembrolizumab in patients with metastatic melanoma resistant to anti-PD-1.
Previous
1
Next
